Business Insights, June 2011, Pages: 164
TheCancerMarketOutlookto 2016 The global cancermarket is becoming increasingly competitive, with two therapeutic classes, namely antineoplastics and cytostatic hormonal treatments, dominating
Business Insights, Nov 2005 TheCancerMarketOutlookto 2010 Thecancermarket has undergone a high degree of innovation led change over the previous five years, which has created strong opportunities for a range of
AMID Co, Sep 2009, Pages: 200
Drugs Export
Market Overview by Drug’s Active Principle
Market Overview by Producers
Pricing Trend
V. BLADDER CANCER TREATMENT DRUGS MARKETOUTLOOK
Bladder Cancer Treatment Drugs Markets Outlook
Decision Resources, Inc., April 2011, Pages: 29
Cancer Biologics Pipeline: Antibodies, Peptides, and Proteins - A Competitive Review Thecancer biologics pipeline - consisting of antibodies, peptides, and proteins - is robust (vetted to 162
AMID Co, Jan 2010, Pages: 223
TREATMENT DRUGS MARKETOUTLOOK
Liver Cancer Treatment Drugs Markets Outlook Overview
Government Regulation
Health Care Insurance Industry Overview
Consumer Spending Trends
Demographic Trends
Health Care
AMID Co, July 2010, Pages: 231
Chinese Markets for Cancer Treatment Drugs China's demand for Cancer Treatment Drugs has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to
AMID Co, Sep 2009, Pages: 188
DRUGS MARKETOUTLOOK
Cervical Cancer Treatment Drugs Markets Outlook Overview
Government Regulation
Health Care Insurance Industry Overview
Consumer Spending Trends
Demographic Trends
AMID Co, Jan 2010, Pages: 211
Monoclonal Antibody
Small Molecules Drug
Growth Factor Inhibitors
Kidney Cancer Treatment Drugs Imports and Exports
Pricing Trend
V. KIDNEY CANCER TREATMENT DRUGS MARKETOUTLOOK
Kidney Cancer
AMID Co, Jan 2010, Pages: 192
Imports and Exports
Pricing Trends
V. CHINA SKIN CANCER TREATMENT DRUGS MARKETOUTLOOK
Skin Cancer Treatment Drugs Markets Outlook
Government Regulations
Health Care Insurance Industry Overview
Markets and Markets, Nov 2011, Pages: 129
Lung Cancer Therapeutics Market (NSCLC & SCLC) - 2010-2020 (Pipeline Assessment and Market Forecast) in G7 countries. Lung cancer is responsible for most of the deaths (due tocancer) across the
AMID Co, Feb 2009, Pages: 189
DRUGS MARKETOUTLOOK
Lung Cancer Treatment Drugs Markets Outlook Overview
Government Regulations
Health Care Insurance Industry Overview
Consumer Spending Trends
Demographic Trends
Health Care Industry
Koncept Analytics, June 2011, Pages: 39
.
Themarket for breast cancer drugs represents an area of potential opportunity in both developed and developing countries. Due to effectiveness and advancement in technology, a large number of companies
Arrowhead Publishers, Aug 2008, Pages: 318
Cancer Therapeutics - Market Insight and R&D Pipeline Analysis Objectives and Scope
The intention of this study is to provide a detailed and thorough analysis of the present and future global market
AMID Co, Sep 2009, Pages: 197
Inhibitors
Growth Factor Inhibitors
Brain Cancer Treatment Drugs Imports and Exports
Pricing Trends
V. CHINA BRAIN CANCER TREATMENT DRUGS MARKETOUTLOOK
Brain Cancer Treatment Drugs Markets Outlook
Arrowhead Publishers, Nov 2009
Lung Cancer Therapeutics MarketOutlook and Pipeline Analysis With over 50% of all non-small cell lung cancer (NSCLC) patients diagnosed at the advanced stages of the disease, and 95% of all small
AMID Co, Sep 2009, Pages: 169
CANCER TREATMENT DRUGS MARKETOUTLOOK
Colon Cancer Treatment Drugs MarketOutlook Overview
Government Regulations
Health Care Insurance Industry Overview
Consumer Spending Trends
Demographic
Markets and Markets, Nov 2011, Pages: 286
market and 8 in pipeline. Growing prostate cancer population (25% increase in the incidence of prostate cancer in mature countries and 40% increase in emerging countries, from 2010 to 2020) is an impetus
Markets and Markets, July 2011, Pages: 228
Lung Cancer Surgery Market (Devices & Treatment Outlook) – Trends & Challenges (2010 – 2015) Lung cancer is the most common type of cancer across the globe. According to WHO, lung cancer is expected
Decision Resources, Inc., March 2010, Pages: 32
cancer vaccines that represent a new means to treat or prevent certain cancers. Efficacy has been disappointing for many vaccines, however, and the development of these vaccines is a high-risk endeavor
TriMark Publications, July 2011, Pages: 267
cancer, some of which are in development for more than one type of the disease, for a total of more than 500 ongoing R&D projects.
The goal of this TriMark Publications report is to review themarket for
